PMID- 31414913
OWN - NLM
STAT- MEDLINE
DCOM- 20200504
LR  - 20200505
IS  - 1744-5078 (Electronic)
IS  - 0927-3948 (Linking)
VI  - 27
IP  - 8
DP  - 2019
TI  - Incidence of Irvine Gass Syndrome after Phacoemulsification with Spectral-Domain 
      Optical Coherence Tomography.
PG  - 1224-1231
LID - 10.1080/09273948.2019.1634215 [doi]
AB  - Purpose: Incidence of significant and non-significant macular edema found using 
      spectral-domain optical coherence tomography (SD-OCT) following cataract 
      surgery.Methods: Prospective, cohort series conducted at the Croix Rousse 
      University Hospital. Significant macular edema (SME) was defined as the presence 
      of fluid with an increase of 30% or more in central subfield macular thickness 
      compared to baseline on SD-OCT at 6 weeks and non-significant macula edema (NSME) 
      as an increase of less than 30%.Results: Nine hundred and twenty-eight eyes in 
      638 patients were included in the study. Incidence of Irvine Gass (IG) syndrome 
      was 9%, 2.3% of patients presented SME, 6.8% NSME. Epiretinal membrane, diabetes, 
      and capsular rupture were significantly associated with a risk of IG. The risk of 
      developing IG in the fellow eye was 23% in cases of IG in the first eye. In total 
      8.4% of all included patients developed chronic IG (duration of more than 
      6 months).Conclusion: This study reports the incidence of IG during 6 months of 
      surgical activity at a French university hospital center.
FAU - Bellocq, David
AU  - Bellocq D
AUID- ORCID: 0000-0002-6839-3168
AD  - Department of Ophthalmology, Croix-Rousse University Hospital, Hospices Civils de 
      Lyon, University of Lyon I, Lyon, France.
AD  - CNRS UMR 5510 Mateis, Lyon, France.
FAU - Mathis, Thibaud
AU  - Mathis T
AD  - Department of Ophthalmology, Croix-Rousse University Hospital, Hospices Civils de 
      Lyon, University of Lyon I, Lyon, France.
AD  - CNRS UMR 5510 Mateis, Lyon, France.
FAU - Voirin, Nicolas
AU  - Voirin N
AD  - EPIMOD, Epidemiology and Modelling, Lyon, France.
FAU - Bentaleb, Zainab Machkour
AU  - Bentaleb ZM
AD  - Department of Ophthalmology, Croix-Rousse University Hospital, Hospices Civils de 
      Lyon, University of Lyon I, Lyon, France.
AD  - CNRS UMR 5510 Mateis, Lyon, France.
FAU - Sallit, Rebecca
AU  - Sallit R
AD  - Department of Ophthalmology, Croix-Rousse University Hospital, Hospices Civils de 
      Lyon, University of Lyon I, Lyon, France.
AD  - CNRS UMR 5510 Mateis, Lyon, France.
FAU - Denis, Philippe
AU  - Denis P
AD  - Department of Ophthalmology, Croix-Rousse University Hospital, Hospices Civils de 
      Lyon, University of Lyon I, Lyon, France.
AD  - CNRS UMR 5510 Mateis, Lyon, France.
FAU - Kodjikian, Laurent
AU  - Kodjikian L
AD  - Department of Ophthalmology, Croix-Rousse University Hospital, Hospices Civils de 
      Lyon, University of Lyon I, Lyon, France.
AD  - CNRS UMR 5510 Mateis, Lyon, France.
LA  - eng
PT  - Journal Article
PT  - Observational Study
DEP - 20190815
PL  - England
TA  - Ocul Immunol Inflamm
JT  - Ocular immunology and inflammation
JID - 9312169
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Female
MH  - Fluorescein Angiography/methods
MH  - Follow-Up Studies
MH  - France/epidemiology
MH  - Fundus Oculi
MH  - Humans
MH  - Incidence
MH  - Macula Lutea/*pathology
MH  - Macular Edema/diagnosis/*epidemiology/etiology
MH  - Male
MH  - Middle Aged
MH  - Phacoemulsification/*adverse effects
MH  - Postoperative Complications/diagnosis/*epidemiology/etiology
MH  - Prospective Studies
MH  - Tomography, Optical Coherence/*methods
MH  - *Visual Acuity
MH  - Young Adult
OTO - NOTNLM
OT  - Incidence
OT  - macular edema
OT  - optical coherence tomography
EDAT- 2019/08/16 06:00
MHDA- 2020/05/06 06:00
CRDT- 2019/08/16 06:00
PHST- 2019/08/16 06:00 [pubmed]
PHST- 2020/05/06 06:00 [medline]
PHST- 2019/08/16 06:00 [entrez]
AID - 10.1080/09273948.2019.1634215 [doi]
PST - ppublish
SO  - Ocul Immunol Inflamm. 2019;27(8):1224-1231. doi: 10.1080/09273948.2019.1634215. 
      Epub 2019 Aug 15.